124 related articles for article (PubMed ID: 37098158)
1. 18 F-FDG PET-Positive Large Pelvic Granuloma Mimicking Malignant Bladder Tumor.
Altintas Taslicay C; Cam I; Civriz AH; Kara O; Demir H
Clin Nucl Med; 2023 Jun; 48(6):e310-e312. PubMed ID: 37098158
[TBL] [Abstract][Full Text] [Related]
2. Fluorodeoxyglucose positron emission tomography (18F-FDG PET)-computed tomography (CT) in the initial staging of bladder cancer: a single institution experience.
Shahait M; Abu-Hijlih R; Farkouh A; Obeidat S; Salah S; Abdlkadir AS; Al-Ibraheem A
J Egypt Natl Canc Inst; 2023 Jul; 35(1):21. PubMed ID: 37455263
[TBL] [Abstract][Full Text] [Related]
3. Delayed imaging of the pelvis with diluted and filled bladder: a simple and efficient method in FDG PET/CT imaging of bladder carcinoma.
Halac M; Aliyev A; Yılmaz S; Ozhan M; Kaya R; Sağer S; Ergül N
Clin Nucl Med; 2012 Aug; 37(8):778-80. PubMed ID: 22785509
[TBL] [Abstract][Full Text] [Related]
4. Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique.
Nayak B; Dogra PN; Naswa N; Kumar R
Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):386-93. PubMed ID: 23179944
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT in Bladder Cancer.
Tagliabue L; Russo G; Lucignani G
Clin Nucl Med; 2016 Dec; 41(12):e522-e524. PubMed ID: 27824327
[TBL] [Abstract][Full Text] [Related]
6. Abdominal Wall Granulomatous Inflammation Mimicking Malignancy on FDG PET/CT.
Shen G; Kuang A
Clin Nucl Med; 2020 Mar; 45(3):234-235. PubMed ID: 31833933
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
[TBL] [Abstract][Full Text] [Related]
8. FDG PET/CT and renal scan demonstrations of carcinoma in the urinary bladder and bladder diverticulum.
Liu Y
Clin Nucl Med; 2013 Jul; 38(7):580-1. PubMed ID: 23478848
[TBL] [Abstract][Full Text] [Related]
9. Incidental detection of increased (18)F-FDG uptake and its follow-up in patients with granulomatous prostatitis after BCG treatment for urinary bladder cancer.
Kim CY; Lee SW; Yoon G; Jeong SY; Ahn BC; Lee J
Hell J Nucl Med; 2014; 17(3):204-7. PubMed ID: 25397626
[TBL] [Abstract][Full Text] [Related]
10. Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer?
Yang Z; Cheng J; Pan L; Hu S; Xu J; Zhang Y; Wang M; Zhang J; Ye D; Zhang Y
Ann Nucl Med; 2012 Aug; 26(7):571-7. PubMed ID: 22763630
[TBL] [Abstract][Full Text] [Related]
11. Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and
Vind-Kezunovic S; Bouchelouche K; Ipsen P; Høyer S; Bell C; Bjerggaard Jensen J
Eur Urol Focus; 2019 Jan; 5(1):90-96. PubMed ID: 28753817
[TBL] [Abstract][Full Text] [Related]
12. Staging
Voskuilen CS; van Gennep EJ; Einerhand SMH; Vegt E; Donswijk ML; Bruining A; van der Poel HG; Horenblas S; Hendricksen K; van Rhijn BWG; Mertens LS
Eur Urol Oncol; 2022 Jun; 5(3):366-369. PubMed ID: 33583752
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.
Verghote F; Poppe L; Verbeke S; Dirix P; Albersen M; De Meerleer G; Berghen C; Ost P; Villeirs G; De Visschere P; De Man K; De Maeseneer D; Rottey S; Van Praet C; Decaestecker K; Fonteyne V
BMC Cancer; 2021 Oct; 21(1):1113. PubMed ID: 34663254
[TBL] [Abstract][Full Text] [Related]
14. Absence of urine production due to renal failure enables clear visualization of primary urinary bladder carcinoma on 18F-FDG PET/CT.
Bertagna F; Motta F; Fisogni S; Lena MS; Lucchini S; Giubbini R
Clin Nucl Med; 2012 Jun; 37(6):611-3. PubMed ID: 22614202
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol Granuloma Masquerading as Gallbladder Carcinoma on 18F-FDG PET/CT.
Fu Z; Chen X; Yang X; Li Q
Clin Nucl Med; 2019 Jun; 44(6):489-490. PubMed ID: 30829860
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT in Urachal Abscess.
Flaus A; Longo MG; Dematons M; Granjon D; Prevot N
Clin Nucl Med; 2019 May; 44(5):e349-e350. PubMed ID: 30829865
[TBL] [Abstract][Full Text] [Related]
17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
18. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L
Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738
[TBL] [Abstract][Full Text] [Related]
19. [F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma.
Jadvar H; Quan V; Henderson RW; Conti PS
Int J Clin Oncol; 2008 Feb; 13(1):42-7. PubMed ID: 18307018
[TBL] [Abstract][Full Text] [Related]
20. Detecting Metastatic Bladder Cancer Using (18)F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography.
Öztürk H
Cancer Res Treat; 2015 Oct; 47(4):834-43. PubMed ID: 25687863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
